Key takeaways Regulatory Status: As of April 2026, BPC-157 is classified as a Category 2 bulk drug substance by the FDA prohibited in compounding under Section 503A and 503B
Ricinus Communis (Castor) Seed Oil*, Oleic/Linoleic/Linolenic Polyglycerides, Hydroxystearic/Linoleic/Oleic Polyglycerides, Cera Alba (Beeswax)/Cire d'abeille, Polyhydroxystearic Acid, Helianthus Annuus (Sunflower) Seed Oil*, Jojoba Esters, Silica, Simmondsia Chinensis (Jojoba) Seed Oil*, Tocopherol, Glycine Soja (Soybean) Oil, Carmine (CI 75470), Mica
The approach focuses on natural signals of fullness, metabolism support, and sustained energy, without complicated dosing or unfamiliar capsules
Email [email protected] with your order number to receive a copy